Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09GDY
|
|||
| Former ID |
DIB003634
|
|||
| Drug Name |
GNI-103
|
|||
| Synonyms |
ED-002; EP-2220; Theradigm-HCV; Hepatitis C virus vaccine (therapeutic), GENimmune; HCV vaccine (therapeutic), IDM/Genencor; Hepatitis C virus vaccine (therapeutic), IDM/Genencor; HCV vaccine (therapeutic), Innogenetics/ IDM /Pharmexa; Hepatitis C virus vaccine (therapeutic), Innogenetics/ IDM/ Pharmexa
Click to Show/Hide
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Discontinued in Phase 1/2 | [1] | |
| Company |
Okairos
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016469) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.